Article ID Journal Published Year Pages File Type
2482398 European Journal of Pharmaceutical Sciences 2008 10 Pages PDF
Abstract

Four alternative matrix formers [Avicel®PH101, Fujicalin® (CaHPO4), Aerosil®200 (SiO2) and Inutec®SP1] were evaluated for their capability in preserving rapid dissolution after spray-drying of nanosuspensions. Model drug compounds selected were cinnarizine (CIN), itraconazole (ITR) and phenylbutazone (PHB) as they showed a decrease in dissolution rate upon spray-drying in the absence of additional matrix formers, yielding release values after 5 min of dissolution (release5 min) of 57.7 ± 1.0% (CIN), 56.3 ± 3.8% (ITR) and 67.4 ± 1.3% (PHB). Compared to the situation without matrix former inclusion, the performance of Avicel®PH101 was good for CIN (release5 min = 90.9 ± 7.7%), intermediate for PHB (release5 min = 81.0 ± 6.4%) and poor for ITR (release5 min = 42.1 ± 4.2%). For Fujicalin®, intermediate (PHB: release5 min = 87.7 ± 3.0%) or poor (CIN: release5 min = 66.1 ± 3.4%; ITR: release5 min = 55.9 ± 5.2%) performance was seen. Results for Aerosil®200 were good for all compounds (CIN: release5 min = 91.5 ± 2.5%; ITR: release5 min = 83.8 ± 3.4%; PHB: release5 min = 95.5 ± 2.4%), indicating that the large specific surface area was in this case translated into good matrix forming capabilities. Finally, the best results were obtained for Inutec®SP1 (CIN: release5 min = 88.7 ± 1.2%; ITR: release5 min = 93.4 ± 2.4%; PHB: release5 min = 101.3 ± 4.9%). Except for Avicel®PH101, Cl-maps from X-ray microanalysis of the itraconazole powders supported the hypothesis that better dispersion of drug in the powders results in faster dissolution.

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Drug Discovery
Authors
, , , , , ,